Herceptin extends life of patients with terminal stomach cancer, study finds

(PhysOrg.com) -- Breast cancer drug Herceptin can extend the lives of patients with incurable stomach cancer by nearly three months, according to an international study involving researchers from the University of Glasgow.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163089110.html">Herceptin extends life of patients with terminal stomach cancer, study finds</a></p> <p>(PhysOrg.com) -- Breast cancer drug Herceptin can extend the lives of patients with incurable stomach cancer by nearly three months, according to an international study involving researchers from the University of Glasgow.</p>